Latest Commercial Agreements News

4DMedical has secured a pivotal three-year contract with SimonMed Imaging to deploy its CT:VQ™ lung imaging technology across over 170 US outpatient centres, while FY26 revenue rose 23% to $7.2 million on record scan volumes and global expansion.

Metallium has validated its Flash Joule Heating technology through extensive testing and multi-reactor operation, advancing towards commercial e-waste processing at its Texas campus in H1 2027.

Swoop Holdings reported a strong quarter with cash reserves rising above $8.8 million and a 4% increase in customer numbers, supported by a new wholesale deal with TPG Telecom and pending proceeds from the Melbourne Fibre project sale.

Vysarn Limited is set to transform its water services platform with the $60 million acquisition of Welltech, funded by a fully underwritten $65.3 million placement. The deal promises over 37% EPS accretion on a pro forma FY26 basis.

LTR Pharma’s SPONTAN shows rapid absorption in Phase II interim data while securing key US commercial deals for ROXUS, setting the stage for a US market entry later this year.

InteliCare has expanded its agreement with Hardi Aged Care by adding 84 beds at Blacktown and initiating a phased Nurse Call system deployment across six facilities, lifting contract value by 13%.

Victory Metals has delivered a major processing breakthrough with a 59-fold upgrade to a 7.1% Total Rare Earth Oxide concentrate from its North Stanmore project, backed by strategic partnerships and government funding.

Viridis Mining's Colossus Demonstration Plant has exceeded metallurgical recovery rates assumed in its Pre-Feasibility Study, operating continuously with promising implications for project economics and financing.

NH3 Clean Energy has completed critical environmental surveys for its WAH2 Project, confirming no threatened species or ecological communities in the development area. This milestone supports upcoming State and Commonwealth approval submissions, advancing the project towards its final investment decision.

Nanoveu’s ECS-DoT edge-AI chip has proven its mettle in live drone trials with up to 51% energy efficiency gains, while the acquisition of Spinoff Robotics adds proprietary drone platforms and engineering talent to accelerate commercialisation.

LTR Pharma has locked in a comprehensive commercial agreement with Strive Pharmacy, cementing its manufacturing and fulfilment infrastructure for the upcoming US launch of ROXUS®.

LTR Pharma has formalised its US commercialisation strategy by signing a definitive agreement with telehealth leader Shed, targeting at least 150,000 ROXUS units in the first year through digital men’s health platforms.